Profiel
David M.
Spencer was the founder of Bellicum Pharmaceuticals, Inc. founded in 2004, where he held the title of Chief Technology Officer from 2018 to 2019.
He also held the position of Professor and Vice Chairman-Pathology & Immunology at Baylor College of Medicine and was the Director & Chief Scientific Officer at Kiromic Biopharma, Inc. Dr. Spencer earned a doctorate degree from the Massachusetts Institute of Technology and an undergraduate degree from the University of California San Diego.
Eerdere bekende functies van David M. Spencer
| Bedrijven | Functie | Einde |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Oprichter | 01-03-2019 |
| KIROMIC BIOPHARMA, INC. | Hoofd Techniek/Wetenschap/O&O | - |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Opleiding van David M. Spencer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Baylor College of Medicine
Baylor College of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kiromic Biopharma, Inc.
Kiromic Biopharma, Inc. BiotechnologyHealth Technology Develops cancer engineered immunotherapies | Health Technology |
















